Delivery Order SPE2DB22D1017-SPE2DB25FG9FB
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,707.63 for 60 tablets of Viberzi 100 mg, a pharmaceutical product used in the treatment of irritable bowel syndrome. This non-set-aside, firm fixed-price contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,711.03 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product for gastrointestinal treatment. This competitively awarded, non-set-aside contract employs firm fixed pricing and carries an ultimate completion date of May 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,707.63 for 60 tablets of Viberzi 100 mg, with a completion date of July 28, 2025. This competitively awarded, firm fixed-price contract represents a pediatric order from the pharmaceutical distributor's extensive portfolio of federal medical supply contracts. The contract was executed on July 25, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,716.59. The award, issued on June 9, 2025, with an ultimate completion date of June 10, 2025, represents a non-set-aside competitive procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,881.75 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a $2,161.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product for gastrointestinal treatment. This non-set-aside order was competitively awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order valued at $2,392.32 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60 count). This contract, executed on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was made competitively and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Viberzi 100 mg tablets (60-count) valued at $1,914.82. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026. The order is set to be completed by June 3, 2025, with...
- The Defense Logistics Agency awarded a delivery order valued at $3,947.10 to AmerisourceBergen Drug Corp for the supply of Viberzi 75 mg tablets (60-count units). This firm fixed-price delivery order, issued on September 4, 2025, with completion targeted for September 5, 2025, represents a direct purchase of pharmaceutical inventory to support federal medical supply requirements. The contract was competitively awarded with no set-aside designation, and performance will be executed from the...
- The Defense Logistics Agency awarded a delivery order valued at $3,415.26 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count package). This firm fixed-price, competitively awarded delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The contract represents a continuation of...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9FBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,707.63 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product used to treat irritable bowel syndrome. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The award was performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and represents a child contract under AmerisourceBergen's larger federal contracting relationships. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The contract vehicle enables the company to supply a comprehensive range of pharmaceuticals, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. This particular delivery order exemplifies the company's role in fulfilling routine pharmaceutical supply requirements within the broader Pharmaceutical Prime Vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/7/25 |